- Home
- MRVI vs MOV Comparison
MRVI vs MOV Comparison
Compare MRVI & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- MOV
- Stock Information
- Founded
- MRVI 2014
- MOV 1961
- Country
- MRVI United States
- MOV United States
- Employees
- MRVI N/A
- MOV N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- MOV Consumer Specialties
- Sector
- MRVI Health Care
- MOV Consumer Discretionary
- Exchange
- MRVI Nasdaq
- MOV Nasdaq
- Market Cap
- MRVI 449.6M
- MOV 416.4M
- IPO Year
- MRVI 2020
- MOV 1993
- Fundamental
- Price
- MRVI $3.69
- MOV $20.16
- Analyst Decision
- MRVI Buy
- MOV Strong Buy
- Analyst Count
- MRVI 7
- MOV 1
- Target Price
- MRVI $4.54
- MOV $31.50
- AVG Volume (30 Days)
- MRVI 1.6M
- MOV 108.8K
- Earning Date
- MRVI 11-06-2025
- MOV 11-25-2025
- Dividend Yield
- MRVI N/A
- MOV 7.19%
- EPS Growth
- MRVI N/A
- MOV N/A
- EPS
- MRVI N/A
- MOV 0.77
- Revenue
- MRVI $192,435,000.00
- MOV $655,597,000.00
- Revenue This Year
- MRVI N/A
- MOV $1.98
- Revenue Next Year
- MRVI $7.27
- MOV N/A
- P/E Ratio
- MRVI N/A
- MOV $25.24
- Revenue Growth
- MRVI N/A
- MOV 0.79
- 52 Week Low
- MRVI $1.67
- MOV $12.85
- 52 Week High
- MRVI $6.21
- MOV $22.20
- Technical
- Relative Strength Index (RSI)
- MRVI 61.86
- MOV 68.57
- Support Level
- MRVI $3.37
- MOV $18.23
- Resistance Level
- MRVI $3.76
- MOV $18.82
- Average True Range (ATR)
- MRVI 0.25
- MOV 0.67
- MACD
- MRVI 0.05
- MOV 0.20
- Stochastic Oscillator
- MRVI 94.02
- MOV 93.10
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.